VERTEX PHARMACEUTICALS INC / MA (VRTX) Executive Compensation
VERTEX PHARMACEUTICALS INC / MA (VRTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VRTX
CIK: 875320
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: MA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerPamela Kelleher
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0000875320-26-000272 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-09-08 | FORM 3 | 0000875320-26-000270 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-28 | FORM 4 | 0000875320-26-000267 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-08-27 | 8-K | 0000875320-26-000264 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | FORM 4 | 0000875320-26-000261 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001958244-26-000559 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0000875320-26-000259 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0000875320-26-000256 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-07-21 | FORM 4 | 0000875320-26-000253 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-07-21 | FORM 4 | 0000875320-26-000251 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | FORM 4 | 0000875320-26-000249 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | FORM 4 | 0000875320-26-000247 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0000875320-26-000245 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0000875320-26-000243 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-06 | 8-K | 0001193125-26-296710 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0000875320-26-000241 | View SEC Doc Filr Page |
| 144 | 2026-07-02 | — | 144 Filing | 0001959173-26-005073 | View SEC Doc Filr Page |
| 144 | 2026-07-02 | — | 144 Filing | 0001959173-26-005057 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001959173-26-005009 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0000875320-26-000239 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001959173-26-004906 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-18 | FORM 4 | 0000875320-26-000237 | View SEC Doc Filr Page |
| 144 | 2026-06-18 | — | 144 Filing | 0001959173-26-004764 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0000875320-26-000235 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001959173-26-004654 | View SEC Doc Filr Page |